Inventor profile of:

Ramesh Krishnamoorthy

City:

Cary, North Carolina

Country:

United States

Published Applications:

17

Last publication date:

2022-12-29

Top Assignees for applications by Ramesh Krishnamoorthy

The entities that hold a legal rights for patent applications filed by inventor Krishnamoorthy Ramesh:

Recent patent applications by Krishnamoorthy Ramesh

Ramesh Krishnamoorthy from Cary, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-12-29
US20220409607A1
Human necessities

Ophthalmic compositions

#2 | 2022-10-20
US20220331308A1
Human necessities

Ophthalmic compositions

#3 | 2022-09-29
US20220304995A1
Human necessities

OPHTHALMIC COMPOSITIONS

#4 | 2018-03-01
US20180055833A1
Human necessities

Ophthalmic compositions

#5 | 2013-11-07
US20130291860A1
Human necessities

Method For Treating Cystic Fibrosis with Inhaled Denufosol

#6 | 2012-01-05
US20120000941A1
Performing operations; transporting

MEDICINE DISPENSER

#7 | 2012-01-05
US20120000936A1
Performing operations; transporting

MEDICINE DISPENSER

#8 | 2010-12-02
US20100305175A1
Human necessities

PHARMACEUTICAL LATRUNCULIN FORMULATIONS

#9 | 2010-04-22
US20100099635A1
Human necessities

Method for treating cystic fibrosis

#10 | 2010-01-07
US20100003334A1
Human necessities

Combination of loteprednol etabonate and tobramycin for topical ophthalmic use

#11 | 2009-04-16
US20090098064A1
Human necessities

METHOD OF TREATING PULMONARY EDEMA OR PULMONARY INFLAMMATION

#12 | 2008-08-14
US20080194544A1
Human necessities

AQUEOUS FORMULATIONS OF EPINASTINE FOR TREATING ALLERGIC RHINITIS

#13 | 2008-05-27
US11935245
-

Method for treating allergic rhinitis without adverse effects

#14 | 2007-11-15
US20070265247A1
Human necessities

METHOD OF REDUCING CONTACT LENS INTOLERANCE WITH NON-DRYING ANTIHISTAMINES

#15 | 2007-09-27
US20070225343A1
Human necessities

Pharmaceutical latrunculin formulations

#16 | 2005-09-08
US20050197303A1
Human necessities

Combination of loteprednol etabonate and tobramycin for topical ophthalmic use

#17 | 2005-05-05
US20050095205A1
Human necessities

Combination of loteprednol etabonate and tobramycin for topical ophthalmic use

InventorID:

513718 ⎘